Notice of Extra Ordinary General Meeting held on 26th December 2025 at Friday.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs has called an EGM on 26 December 2025 in Indore to seek shareholder approval on five items. Two items seek approval to confirm the appointment of Ms. Ritu Tiwari and Ms. Nikita Sinha as Non-Executive Independent Directors for a 5-year term (8 October 2025 to 7 October 2030). A third item seeks approval to pay remuneration of up to Rs. 72 lakhs per annum to Executive Director Mr. Kuniamuthur Nanjappan Anand, despite the company having incurred losses in FY 2024-25. A fourth, significant item seeks authorization for the Board to make loans, give guarantees, or invest up to Rs. 200 crores under Sections 185 and 186 of the Companies Act. The fifth item seeks approval to appoint Mrs. Twinkle Agarwal as Secretarial Auditor for five financial years (2025-26 to 2029-30). E-voting opens on 23 December 2025 and closes on 25 December 2025.
Routine governance items for shareholders' approval, but the Rs. 200 crore borrowing/investment limit and director remuneration approval despite losses are notable and could raise governance concerns among retail investors.